PRIMARY STUDY

Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians

Key Findings:  The authors posit that while cannabis may improve symptom management (e.g. abdominal pain, joint pain, abdominal cramping, and diarrhea), it has not been proven to help with inflammation or to fundamentally correct underlying pathologies of IBD. In addition, the authors are concerned about the potential adverse effects of cannabinoid-based therapeutics.

Type of Study:  Meta-analysis

Study Result:  Inconclusive

Study Location(s):  United States

Year of Pub:  2021


Cannabinoids Studied:  Cannabinoid (unspecified)

Phytocannabinoid Source:  Unspecified